Health Source: A subsidiary company of the Beauty Group has received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration.

Health Element announcement, the holding subsidiary Lijie Group has received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration, approving the company's application for the clinical trial of JP-1366 tablets for the indication of "eradicating Helicobacter pylori in combination with appropriate antibiotics".